| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparison of advanced semi-quantitative amyloid PET analysis methods
|
Peira, Enrico
|
|
|
49 |
12 |
p. 4097-4108
|
article
|
| 2 |
A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death
|
Ho Shon, Ivan
|
|
|
49 |
12 |
p. 4037-4047
|
article
|
| 3 |
Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy
|
Xue, Song
|
|
|
49 |
12 |
p. 4064-4072
|
article
|
| 4 |
A prospective head-to-head comparison of 68 Ga-NOTA-3P-TATE-RGD and 68 Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours
|
Jiang, Yuanyuan
|
|
|
49 |
12 |
p. 4218-4227
|
article
|
| 5 |
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up
|
Hartrampf, Philipp E.
|
|
|
49 |
12 |
p. 4262-4270
|
article
|
| 6 |
Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis
|
Alberts, Ian
|
|
|
49 |
12 |
p. 4252-4261
|
article
|
| 7 |
Complementary value of metabolic and tau PET imaging in the diagnosis of corticobasal degeneration
|
Liang, Menglin
|
|
|
49 |
12 |
p. 4286-4288
|
article
|
| 8 |
Correction to: Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
|
Rufini, Vittoria
|
|
|
49 |
12 |
p. 4289
|
article
|
| 9 |
Correction to: Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography
|
Long, Yu
|
|
|
49 |
12 |
p. 4290-4291
|
article
|
| 10 |
Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
|
Rufini, Vittoria
|
|
|
49 |
12 |
p. 4182-4193
|
article
|
| 11 |
[64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation
|
Xie, Fang
|
|
|
49 |
12 |
p. 3964-3972
|
article
|
| 12 |
CXCR4-targeted theranostics in oncology
|
Buck, Andreas K.
|
|
|
49 |
12 |
p. 4133-4144
|
article
|
| 13 |
Diagnostic performance of [18F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis
|
Mirshahvalad, Seyed Ali
|
|
|
49 |
12 |
p. 4205-4217
|
article
|
| 14 |
Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks
|
Zaker, Neda
|
|
|
49 |
12 |
p. 4048-4063
|
article
|
| 15 |
Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG
|
Chen, Wanqi
|
|
|
49 |
12 |
p. 4145-4155
|
article
|
| 16 |
Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management
|
Qin, Chunxia
|
|
|
49 |
12 |
p. 4228-4240
|
article
|
| 17 |
Improving the imaging diagnostic strategy for pulmonary artery masses based on 18F-FDG PET/CT integrated with CTPA
|
Hong, Cheng
|
|
|
49 |
12 |
p. 4109-4121
|
article
|
| 18 |
Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
|
Quach, Stefanie
|
|
|
49 |
12 |
p. 4282-4283
|
article
|
| 19 |
In vivo detection of hydrogen sulfide in the brain of live mouse: application in neuroinflammation models
|
Nam, Bora
|
|
|
49 |
12 |
p. 4073-4087
|
article
|
| 20 |
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
|
Gafita, Andrei
|
|
|
49 |
12 |
p. 4271-4281
|
article
|
| 21 |
Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer—phase I/II study
|
Lin, Yan-Song
|
|
|
49 |
12 |
p. 4171-4181
|
article
|
| 22 |
PET/CT imaging of CSF1R in a mouse model of tuberculosis
|
Foss, Catherine A.
|
|
|
49 |
12 |
p. 4088-4096
|
article
|
| 23 |
PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617
|
Lu, Qiaomiao
|
|
|
49 |
12 |
p. 4000-4013
|
article
|
| 24 |
Preclinical evaluation and pilot clinical study of [18F]AlF-NOTA-FAPI-04 for PET imaging of rheumatoid arthritis
|
Ge, Luna
|
|
|
49 |
12 |
p. 4025-4036
|
article
|
| 25 |
Predicting response of micrometastases with MIRDcell V3: proof of principle with 225Ac-DOTA encapsulating liposomes that produce different activity distributions in tumor spheroids
|
Katugampola, Sumudu
|
|
|
49 |
12 |
p. 3989-3999
|
article
|
| 26 |
Primary biphasic synovial sarcoma of the liver with multiple bone metastases detected by PET/CT
|
Liu, Miao
|
|
|
49 |
12 |
p. 4284-4285
|
article
|
| 27 |
PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers
|
An, Shuxian
|
|
|
49 |
12 |
p. 3973-3976
|
article
|
| 28 |
Repair of α-particle-induced DNA damage in peripheral blood mononuclear cells after internal ex vivo irradiation with 223Ra
|
Göring, Lukas
|
|
|
49 |
12 |
p. 3981-3988
|
article
|
| 29 |
Reproducibility of quantitative coronary calcium scoring from PET/CT attenuation maps: comparison to ECG-gated CT scans
|
Pieszko, Konrad
|
|
|
49 |
12 |
p. 4122-4132
|
article
|
| 30 |
Shining new light on lung cancer diagnosis using a pafolacianine molecular tracer
|
Kramer, T.
|
|
|
49 |
12 |
p. 3979-3980
|
article
|
| 31 |
SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management—the EANM perspective
|
Petranović Ovčariček, Petra
|
|
|
49 |
12 |
p. 3959-3963
|
article
|
| 32 |
Targeted detection of cancer cells during biopsy allows real-time diagnosis of pulmonary nodules
|
Kennedy, Gregory T.
|
|
|
49 |
12 |
p. 4194-4204
|
article
|
| 33 |
The era of prostate-specific membrane antigen (PSMA)–based theranostics for hepatocellular carcinoma is upcoming: are we ready for it?
|
Filippi, Luca
|
|
|
49 |
12 |
p. 3977-3978
|
article
|
| 34 |
The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth
|
Gertsenshteyn, Inna
|
|
|
49 |
12 |
p. 4014-4024
|
article
|
| 35 |
The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma
|
Wang, Xiaoyan
|
|
|
49 |
12 |
p. 4241-4251
|
article
|
| 36 |
Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography
|
Long, Yu
|
|
|
49 |
12 |
p. 4156-4170
|
article
|
Journal description